Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide.

Source:http://linkedlifedata.com/resource/pubmed/id/417160

Download in:

View as

General Info

PMID
417160